Gene · 200315
Papers1,983
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 1,983
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G and APOBEC3H in pancreatic adenocarcinoma. | Front Mol Biosci | 2022 | 36339709 | PubTator, text mining | PubMed |
| Multiplexed base editing through Cas12a variant-mediated cytosine and adenine base editors. | Commun Biol | 2022 | 36323848 | PubTator, text mining | PubMed |
| Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men. | Sci Rep | 2022 | 36316463 | PubTator, text mining | PubMed |
| Design, Synthesis, and Evaluation of a Cross-Linked Oligonucleotide as the First Nanomolar Inhibitor of APOBEC3A. | Biochemistry | 2022 | 36302365 | PubTator, text mining | PubMed |
| Epitranscriptome Analysis of Oxidative Stressed Retinal Epithelial Cells Depicted a Possible RNA Editing Landscape of Retinal Degeneration. | Antioxidants (Basel) | 2022 | 36290689 | PubTator, text mining | PubMed |
| Epigenetic analysis of cell-free DNA by fragmentomic profiling. | Proc Natl Acad Sci U S A | 2022 | 36288287 | PubTator, text mining | PubMed |
| Consecutive BNT162b2 mRNA vaccination induces short-term epigenetic memory in innate immune cells. | JCI Insight | 2022 | 36282593 | PubTator, text mining | PubMed |
| Addressing the benefits of inhibiting APOBEC3-dependent mutagenesis in cancer. | Nat Genet | 2022 | 36280735 | PubTator, text mining | PubMed |
| Bisulfite-Free and Single-Base Resolution Detection of Epigenetic DNA Modification of 5-Methylcytosine by Methyltransferase-Directed Labeling with APOBEC3A Deamination Sequencing. | Anal Chem | 2022 | 36280344 | PubTator, text mining | PubMed |
| Modulation of DNA Methylation/Demethylation Reactions Induced by Nutraceuticals and Pollutants of Exposome Can Promote a C > T Mutation in the Breast Cancer Predisposing Gene PALB2 | Epigenomes | 2022 | 36278678 | PubTator, text mining | PubMed |
| Emerging Trends in the Pathological Research of Human Papillomavirus-positive Oropharyngeal Squamous Cell Carcinoma. | J Clin Transl Pathol | 2022 | 36275841 | PubTator, text mining | PubMed |
| Synonymous nucleotide changes drive papillomavirus evolution. | Tumour Virus Res | 2022 | 36265836 | PubTator, text mining | PubMed |
| Genetic susceptibility of bladder cancer in the Lebanese population. | BMC Med Genomics | 2022 | 36253817 | PubTator, text mining | PubMed |
| Trim69 is a microtubule regulator that acts as a pantropic viral inhibitor. | Proc Natl Acad Sci U S A | 2022 | 36251989 | PubTator, text mining | PubMed |
| Erratum: Exploring APOBEC3A and APOBEC3B substrate specificity and their role in HPV positive head and neck cancer. | iScience | 2022 | 36248736 | PubTator, text mining | PubMed |
| Retasking of canonical antiviral factors into proviral effectors. | Curr Opin Virol | 2022 | 36242894 | PubTator, text mining | PubMed |
| Invasion-Associated Reorganization of Laminin 332 in Oral Squamous Cell Carcinomas: The Role of the Laminin γ2 Chain in Tumor Biology, Diagnosis, and Therapy. | Cancers (Basel) | 2022 | 36230826 | PubTator, text mining | PubMed |
| The Drivers, Mechanisms, and Consequences of Genome Instability in HPV-Driven Cancers. | Cancers (Basel) | 2022 | 36230545 | PubTator, text mining | PubMed |
| Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial. | Nat Commun | 2022 | 36216827 | PubTator, text mining | PubMed |
| Development of a versatile high-throughput mutagenesis assay with multiplexed short-read NGS using DNA-barcoded supF shuttle vector library amplified in E. coli. | Elife | 2022 | 36214452 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/200315/papers?page=22